ClinicalTrials.gov
ClinicalTrials.gov Menu

Biweekly Docetaxel in Patients With Metastatic Breast Cancer.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02041351
Recruitment Status : Completed
First Posted : January 22, 2014
Last Update Posted : January 27, 2016
Sponsor:
Information provided by (Responsible Party):
Jesus Livio Jimenez Santos, Centro Universitario contra el Cáncer

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : January 2014
  Actual Study Completion Date : December 2015